Boiron USA (BOI) Stock Price & News

BOI:EPA

Boiron USA

17,90 €

-0,56%

(-0,10) 1D

23-окт., 16:35:01 GMT+1 · EUR

All symbols

	Symbol	Price	Change	% Change

Generating top insights for BOI...

Open

17,95 €

High

18,20 €

Low

17,55 €

Mkt. cap

316,72 млн

Avg. vol.

6,55 миң

Volume

0,00

P/E ratio

11,87

52-wk high

32,25 €

52-wk low

16,90 €

EPS

1,51 €

Shares outstanding

17,55 млн

No. of employees

3 миң

Open

17,95 €

High

18,20 €

Low

17,55 €

Mkt. cap

316,72 млн

Avg. vol.

6,55 миң

Volume

0,00

P/E ratio

11,87

52-wk high

32,25 €

52-wk low

16,90 €

EPS

1,51 €

Shares outstanding

17,55 млн

No. of employees

3 миң

Related stocks

Compagnie des Alpes SA

News stories

From web sources and news partners

TradingView

43 мүнөт мурун

Hong Kong names Nasdaq-listed Solana Company a strategic enterprise

Barron's

12 мүнөт мурун

HANetf Nasdaq 100 Daily Covered Call UCITS ETF Overview (QQQI)

Stocktwits

1 саат мурун

Nasdaq Futures Slip Amid Tech Selloff While S&P 500, Dow Edge Higher Ahead Of Crucial Earnings Week: IREN, CRWV, NBIS, MRNA, EWZ In Focus

Bloomberg.com

14 саат мурун

Zero-Day Option Traders Are Betting Against Big S&P 500 Swings

Profile

Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index. In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations. Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs". Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia

About Boiron USA

CEO-

Employees2,62 миң

Founded1932-ж., 7-июн.

Headquarters-

SectorPharmaceutical industry

Websiteboiron.fr

All values in EUR	2025-ж. сен.	2025-ж. дек.	2026-ж. мар.	2026-ж. июн.
Revenue	127,73 млн	127,73 млн	120,16 млн	120,16 млн
Cost of goods sold	35,40 млн	35,40 млн	33,53 млн	33,53 млн
Cost of revenue	35,40 млн	35,40 млн	33,53 млн	33,53 млн
Research and development expenses	1,56 млн	1,56 млн	1,44 млн	1,44 млн
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	79,26 млн	79,26 млн	79,95 млн	79,95 млн
Operating expense	77,52 млн	77,52 млн	81,88 млн	81,88 млн
Total operating expenses	112,92 млн	112,92 млн	115,41 млн	115,41 млн
Operating income	14,81 млн	14,81 млн	4,76 млн	4,76 млн
Other non operating income	-1,13 млн	-1,13 млн	-2,29 млн	-2,29 млн
EBT including unusual items	13,82 млн	13,82 млн	4,02 млн	4,02 млн
EBT excluding unusual items	13,16 млн	13,16 млн	2,75 млн	2,75 млн
Income tax expense	3,18 млн	3,18 млн	1,56 млн	1,56 млн
Effective tax rate	22,99%	22,99%	38,90%	38,90%
Other operating expenses	-3,30 млн	-3,30 млн	488,00 миң	488,00 миң
Net income	10,64 млн	10,64 млн	2,46 млн	2,46 млн
Net profit margin	8,33%	8,33%	2,04%	2,04%
Earnings per share	-	-	-	-
Interest and investment income	653,00 миң	653,00 миң	636,50 миң	636,50 миң
Interest expense	-335,00 миң	-335,00 миң	-410,00 миң	-410,00 миң
Net interest expenses	318,00 миң	318,00 миң	226,50 миң	226,50 миң
Depreciation and amortization charges	-	-	-	-
EBITDA	18,06 млн	18,06 млн	11,17 млн	11,17 млн
Gain or loss from assets sale	-446,00 миң	-446,00 миң	-	-

Finance

Ask anything